Arachnoid Cysts Companies specialize in researching, developing, and manufacturing medical solutions for arachnoid cysts, abnormal fluid-filled sacs within the arachnoid membrane of the brain. These companies focus on innovative treatments, advanced diagnostics, and patient care. They aim to improve the understanding and management of arachnoid cysts, enhancing overall neurological health.
Latest Arachnoid Cysts Companies Updates:
Sophysa's Collaboration with Solvay's Solviva Biomaterials: In October 2014, Sophysa, a medical device company specializing in neurosurgical implants, announced a collaboration with Solvay's Solviva Biomaterials to use its Eviva polysulfone (PSU) resin for manufacturing implantable brain shunt valves. These valves are crucial for draining excess fluid from the skull in patients with arachnoid cysts causing pressure build-up.
Emerging Players and Innovations: While major players in the broader neurosurgical devices market might not solely focus on arachnoid cysts, smaller, innovative companies are contributing to advancements. For instance, companies like Aesculap and Medtronic are developing new shunt technologies and drainage systems for better cyst management.
List of Arachnoid Cysts Key companies in the market:
Arachnoid Cysts Market Scenario
The arachnoid cysts market is expected to grow USD 2.12 Billion at a CAGR 5.50% during the forecast period 2023 to 2030.Arachnoid cysts are a type of brain cyst cause between the split of the arachnoid membrane, which is one of the 3 layers of the tissue that covers the brain and the spinal cord.
Rising number of patients suffering from meningitis, tumors and head injuries are expected to drive the growth of the market. According to a report published by the American Society of Clinical Oncology in November 2017, an estimated 23,880 people are expected to be diagnosed with brain and spinal cord tumors in 2017.
Moreover, favorable healthcare expenditures boost the growth of the market. However, lack of knowledge may hamper the market growth during the assessment period.
Segmentation
The arachnoid cysts market has been segmented into type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into, intracranial and spinal. Intracranial arachnoid cysts are expected to hold the largest market share because of high incidences of the type. Spinal arachnoid cysts are expected to grow at the fastest CAGR owing to rising cases of spinal injuries resulting in cysts.
The market, by diagnosis, has been segmented into, CT scan, MRI scan, prenatal ultrasound, and other tests.
The market, by treatment, has been segmented into, permanent drainage system surgery, fenestration, and endoscopic cyst fenestration.
The market, by region, has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The arachnoid cysts market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European arachnoid cysts market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The arachnoid cysts market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The arachnoid cysts market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
Spiegelberg GmbH & Co. KG ., Sophysa, Aesculap, Inc., DePuy Synthes, Medtronic, Integra LifeSciences, Christoph Miethke GmbH & Co. KG, Tokibo Co. Ltd., Boston Neurosciences, Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Hitachi Medical Systems Europe, Siemens Healthcare Private Limited and FUJIFILM SonoSite, Inc. are some of the key players in the arachnoid cysts market.
Regional Market Summary
Global Arachnoid Cysts Market Share (%), by Region, 2017
Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)
Geographically, the Americas is anticipated to dominate the arachnoid cysts market owing to technological advancements and rising prevalence of tumor & meningitis. According to a report published by American Society of Clinical Oncology in November 2017, about 3,560 children are expected to be diagnosed with a brain tumor or CNS tumor in 2017.
Europe is expected to hold the second largest position in the arachnoid cysts market. The market growth in this region is attributed to the growing prevalence of spinal cord & brain tumors and increasing healthcare expenditure. According to Cancer Research UK, 11,432 new cases of brain tumors were reported in 2015 in the UK.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising awareness of tumors & meningitis and government support for healthcare facilities. According to a study published by the European Society for Medical Oncology in January 2016, there were 4.3 million new cases of cancer in China in 2015.
On the other hand, the Middle East & Africa has the least market share. Majority of the market of this region is expected to be held by the Middle East region due to growing government initiatives for the improvement of the healthcare sector.
Arachnoid Cysts Market, by Type
Arachnoid Cysts Market, by Diagnosis
Arachnoid cysts Market, by Treatment
Arachnoid Cysts Market, by Region
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)